Evidence map›Paper›PMID 42852605›Full record

ArticleJournal of global health2026

Influenza vaccine protection and contact patterns among outpatients with influenza-like illness during the 2024-2025 season in China: a test-negative case-control study.

Luping Chen, Jia Mi, Yingxuan Wang, Zhisheng Chen, Juping Wang, Zihao Guo, Haogao Gu, Qiaoge Chi, Lirong Cao, Ruijuan Ji and 12 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Luping Chen *Institute of Medical Engineering Interdisciplinary Research, College of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, Xinjiang, China.
Jia Mi *Institute of Medical Engineering Interdisciplinary Research, College of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, Xinjiang, China.
Yingxuan Wang *School of Public Health, Tianjin Medical University, Tianjin, China.
Zhisheng Chen *Ili Kazakh Autonomous Prefecture Center for Disease Control and Prevention, Ili Kazakh Autonomous Prefecture, China.
Juping Wang *Ili Kazakh Autonomous Prefecture Center for Disease Control and Prevention, Ili Kazakh Autonomous Prefecture, China.
Zihao GuoJC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Haogao GuSchool of Public Health, The University of Hong Kong, Hong Kong, China.
Qiaoge ChiDepartment of Biomedical Sciences, City University of Hong Kong, Hong Kong, China.
Lirong CaoJC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Ruijuan JiHealth Commission of Ili Kazakh Autonomous Prefecture, Ili Kazakh Autonomous Prefecture, China.
Kamuranni LuotebulaIli Kazakh Autonomous Prefecture Center for Disease Control and Prevention, Ili Kazakh Autonomous Prefecture, China.
Shengmei YangIli Kazakh Autonomous Prefecture Center for Disease Control and Prevention, Ili Kazakh Autonomous Prefecture, China.
Yan KongInstitute of Medical Engineering Interdisciplinary Research, College of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, Xinjiang, China.
Kailu WangJC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Sheikh Taslim AliSchool of Public Health, The University of Hong Kong, Hong Kong, China.
Daihai HeDepartment of Mathematics, The Hong Kong Polytechnic University, Hong Kong, China.
Marc Kc ChongJC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, China.
Shi ZhaoSchool of Public Health, Tianjin Medical University, Tianjin, China.
Kai WangInstitute of Medical Engineering Interdisciplinary Research, College of Medical Engineering and Technology, Xinjiang Medical University, Urumqi, Xinjiang, China.
Yuantao Hao *Peking University Center for Public Health and Epidemic Preparedness & Response, MoE Key Laboratory of Epidemiology of Major Diseases, Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
David Sc Hui *Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
Zijian Feng *School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Continuous monitoring of both influenza vaccine protection and behavioural determinants of infection is important for understanding related risks. Evidence on influenza vaccine effectiveness (VE) in China during the 2024-2025 season, however, remains limited. We aimed to assess influenza VE among healthcare-seeking outpatients with influenza-like illness (ILI) and to examine the contact patterns associated with infection risk. Methods: We enrolled 928 outpatients with ILI from three sentinel hospitals in Ili Kazakh Autonomous Prefecture, China, between December 2024 and March 2025 in a test-negative case-control study. We confirmed influenza infection using reverse transcription-polymerase chain reaction and collected vaccination history and social contact frequency and duration through questionnaires. We estimated VE using logistic regression with covariate adjustment, and otherwise analysed social contact patterns and performed exploratory sequencing of six randomly selected influenza-positive samples. Results: Our full sample comprised 928 participants. We excluded 21 infants younger than 6 months from the VE analysis and included 907 participants, of whom 121 tested positive and 786 tested negative. The overall adjusted VE against medically attended influenza was 42.3% (95% credible interval = 11.1-62.5). In the analysis of social contacts for all 928 participants, test-positive children aged 0-10 years and adults aged 65 years or older reported more frequent and longer social contact than their test-negative counterparts. Exploratory sequencing of six samples suggested no major antigenic mismatch with the vaccine strains, but the very small number of sequenced samples limits the generalisability of this finding. Conclusions: Influenza vaccination provided moderate protection against medically attended influenza, while contact patterns were associated with infection risk among children and older adults. Combined vaccination and behavioural interventions warrant further evaluation, as the observational design of this study and its use of self-reporting data limit causal inference.

Indexed as

Influenza, HumanInfluenza VaccinesOutpatientsVaccine EfficacyAdolescentAdultAgedCase-Control StudiesChildChild, PreschoolChinaFemaleHumansInfantMaleMiddle AgedInfluenza VaccinesChinacontact patternsinfluenzainfluenza vaccinationtest-negative designvaccine effectiveness

Identifiers

PMID42852605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.